Literature DB >> 17159579

Viscosupplementation for knee osteoarthritis: a systematic review.

Jon G Divine1, Bohdanna T Zazulak, Timothy E Hewett.   

Abstract

Due to the rising number of patients affected by osteoarthritis (OA), appropriate management decisions for minimizing pain and improving physical function for patients with OA are important. Hyaluronic acid (HA) knee injections have become a common tool for the management of OA of the knee, and the number of randomized controlled trials on the efficacy and safety of this treatment is growing. We performed a systematic review of the five published meta-analyses, which include single- or double-blinded randomized trials performed at one center or multiple centers (Level I evidence). Within each meta-analysis, a quality assessment tool for each trial was used based on outcome measures of OA-related pain, disease severity, trial period, and mean efficacy. We analyzed and compared the data collection and qualitative analysis methods, outcomes, and conclusions presented for each meta-analysis. Although they used different strategies, each used scientifically sound methods for analysis of many of the same trials; however, each used a different measure of trial quality and heterogeneity. Despite these differences, all come to a similar conclusion that when the strictest quality tools and interpretation of heterogeneity are used, Level I evidence demonstrates that the use of HA in patients with OA results in modest improvement in validated outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17159579     DOI: 10.1097/BLO.0b013e31802f5421

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  30 in total

Review 1.  [Non-surgical treatment of osteoarthritis of large joints - new aspects].

Authors:  Ernst Wagner
Journal:  Wien Med Wochenschr       Date:  2009

2.  Adding triamcinolone improves viscosupplementation: a randomized clinical trial.

Authors:  Gustavo Constantino de Campos; Marcia U Rezende; Alexandre F Pailo; Renato Frucchi; Olavo Pires Camargo
Journal:  Clin Orthop Relat Res       Date:  2012-10-26       Impact factor: 4.176

3.  A synthetic polymeric biolubricant imparts chondroprotection in a rat meniscal tear model.

Authors:  Michel Wathier; Benjamin A Lakin; Benjamin G Cooper; Prashant N Bansal; Alison M Bendele; Vahid Entezari; Hideki Suzuki; Brian D Snyder; Mark W Grinstaff
Journal:  Biomaterials       Date:  2018-08-07       Impact factor: 12.479

4.  Bench to Bedside: Platelet-rich Plasma-How Do We Adequately "Untranslate" Translational "Breakthroughs" in an After-market Setting?

Authors:  Benjamin K Potter
Journal:  Clin Orthop Relat Res       Date:  2016-07-22       Impact factor: 4.176

Review 5.  Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: a Bayesian network meta-analysis.

Authors:  Filippo Migliorini; Arne Driessen; Valentin Quack; Nadja Sippel; Brian Cooper; Yasser El Mansy; Markus Tingart; Jörg Eschweiler
Journal:  Arch Orthop Trauma Surg       Date:  2020-07-28       Impact factor: 3.067

Review 6.  The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis.

Authors:  Antonio Gigante; Leonardo Callegari
Journal:  Rheumatol Int       Date:  2010-11-28       Impact factor: 2.631

Review 7.  Hyaluronic acid (Supartz®): a review of its use in osteoarthritis of the knee.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2010-11-01       Impact factor: 3.923

8.  Hyaluronic acid-based hydrogels containing covalently integrated drug depots: implication for controlling inflammation in mechanically stressed tissues.

Authors:  Longxi Xiao; Zhixiang Tong; Yingchao Chen; Darrin J Pochan; Chandran R Sabanayagam; Xinqiao Jia
Journal:  Biomacromolecules       Date:  2013-10-23       Impact factor: 6.988

Review 9.  [Conservative local therapy of inflammation of joints: local invasive forms of therapy].

Authors:  S Rehart; I Arnold; M Fürst
Journal:  Z Rheumatol       Date:  2007-09       Impact factor: 1.372

10.  Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.

Authors:  X Chevalier; J Jerosch; P Goupille; N van Dijk; F P Luyten; D L Scott; F Bailleul; K Pavelka
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.